Viewing nowRosumin 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
NexPharm Korea Co., Ltd.

MFDS item code 201707675 · Approved 2017.10.31 · Insurance code 662503720
Treatment of dyslipidemia; inhibition of atherosclerosis progression; reduction of cardiovascular disease risk
This medication is primarily used as an adjunctive therapy when dietary changes and exercise alone do not control primary hypercholesterolemia and mixed dyslipidemia patients. It is also beneficial in the treatment of patients with homozygous familial hypercholesterolemia or dysbetalipoproteinemia. It is particularly used to lower cholesterol levels in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. This drug effectively lowers total cholesterol and LDL cholesterol to target levels, delaying the progression of atherosclerosis. Additionally, it helps reduce the risk of stroke, myocardial infarction, and revascularization procedures in high-risk patients with elevated high-sensitivity C-reactive protein. Consequently, it is widely used in the management of cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, regardless of meals. The initial dose is 5 milligrams once daily. If a greater reduction in LDL-cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is sufficient for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to the LDL-cholesterol level, treatment goal, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, whereas an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
10 to 17 years of age: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Adjust the dose individually for each patient according to the recommended treatment goal. Adjust the dose at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, patients allergic to any components of this medication or those with active liver diseases should not take it. Patients with muscle disorders or severe renal impairment also should avoid taking this medication. Women who are pregnant or breastfeeding, and women of childbearing age who do not use appropriate contraception should also avoid this medication. This medication contains lactose, and it is important for individuals with lactose intolerance or related genetic disorders to refrain from taking it. When taking this medication, caution is advised if consuming alcohol excessively or if there is a history of liver disease. It is advisable to have regular liver function tests to monitor one’s condition. Patients with hypothyroidism or nephrotic syndrome must treat the underlying cause of their disorders before taking this medication. If symptoms of muscle pain or weakness occur, inform healthcare professionals immediately and undergo necessary tests. Particularly, if muscle enzyme levels significantly rise, treatment may need to be halted. Rarely, severe skin reactions or liver damage can occur in some patients when taking this medication; therefore, if skin rashes, jaundice, or severe fatigue appear, discontinue the medication immediately and consult a physician. This medication may interact with other drugs, so it is essential to inform healthcare providers about any other medications being taken. Caution is particularly needed when taken with specific antivirals, immunosuppressants, antifungals, certain antibiotics, and fibrate class medications. Women who are pregnant or planning to become pregnant must consult a specialist before deciding whether to take this medication, and breastfeeding mothers should avoid it as well. In case of overdose, since there is no specific antidote, one should visit a medical institution immediately for appropriate treatment and evaluation. This medication is not known to significantly affect driving or equipment operation, but caution is advised as dizziness may occur.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, hives, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, eosinophilia with systemic symptoms drug reaction syndrome, drug-induced lichenoid rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, memory decline, forgetfulness, amnesia, memory disorders, confusion, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, sensory disturbances, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best kept at room temperature between 1°C and 30°C. Storing it this way will help maintain the drug's efficacy for a longer time.
Pink, round film-coated tablet
28 tablets/Alu-Alu, 30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
NexPharm Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.